3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
38
Neoplasm Metastasis
16
Leukemia, Myeloid, Acute
13
Skin Neoplasms
10
Kidney Neoplasms
10
Leukemia
9
Carcinoma, Renal Cell
9
Neoplasms
7
Ovarian Neoplasms
6
Breast Neoplasms
6
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Congenital Abnormalities
4
Neuroblastoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Recurrence
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Lymphoma, Mantle-Cell
2
Hodgkin Disease
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Interventions
fludarabine phosphate
12
Mycophenolic Acid
12
Cyclophosphamide
11
Whole-Body Irradiation
10
Cyclosporine
10
Cord Blood Stem Cell Transplantation
9
Peripheral Blood Stem Cell Transplantation
7
Busulfan
6
Tacrolimus
5
Radiotherapy
5
fludarabine
4
Antilymphocyte Serum
4
Thiotepa
3
Methotrexate
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Etoposide
3
Cyclosporins
3
sargramostim
2
merphos
2
Methylprednisolone
2
Decitabine
2
Cytarabine
2
vatalanib
1
poly ICLC
1
lintuzumab
1
entinostat
1
Vorinostat
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia, Refractory
×
Interleukin-2
×
Clear all
No trials found.